BIOS Fund II, LP - Insider Non-Derivative Transactions at Lantern Pharma Inc. (LTRN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 29, 2024, BIOS Fund II, LP's relationship to Lantern Pharma Inc. (LTRN) is TenPercentOwner, and currently has 450,118 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LTRN insiders.
Data Source: SEC.
BIOS Fund II, LP - Insider Non-Derivative Transactions of LTRN Common Stock
BIOS Fund II, LP - Insider Non-Derivative Transactions at LTRN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 1, 2024 | Sell -- (Common Stock) | 1832 | 4.87 | 60256 |
| Mar 1, 2024 | Sell -- (Common Stock) | 4185 | 4.87 | 137832 |
| Mar 1, 2024 | Sell -- (Common Stock) | 13686 | 4.87 | 450118 |
| Feb 29, 2024 | Sell -- (Common Stock) | 6909 | 4.85 | 62088 |
| Feb 29, 2024 | Sell -- (Common Stock) | 15780 | 4.85 | 142017 |
| Feb 29, 2024 | Sell -- (Common Stock) | 51608 | 4.85 | 463804 |
| Feb 28, 2024 | Sell -- (Common Stock) | 4649 | 4.4 | 68997 |
| Feb 28, 2024 | Sell -- (Common Stock) | 10620 | 4.4 | 157797 |
| Feb 28, 2024 | Sell -- (Common Stock) | 34731 | 4.4 | 515412 |